South Australian Scleroderma Register: Autoantibodies as predictive biomarkers of phenotype and outcome

International Journal of Rheumatic Diseases

Volumn 15, Issue 1, 2012, Pages 102-109

  Graf, Scott W ^a   Hakendorf, Paul ^b   Lester, Sue ^c   Patterson, Karen ^d   Walker, Jenny G ^a   Smith, Malcolm D ^a   Ahern, Michael J ^a   Roberts Thomson, Peter J ^d  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d SA Pathology   (Australia)

Author keywords

Biomarkers; Clinical features; EUROLINE; Scleroderma; Scleroderma autoantibodies; Survival; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; FIBRILLARIN; SCL 70 ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; AUSTRALIA; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; HUMAN; IMMUNOBLOTTING; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOSITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; SURVIVAL TIME;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SOUTH AUSTRALIA; TIME FACTORS;

EID: 84857042264     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01688.x     Document Type: Article

References (19)

1. LeRoy EC, Black C, Fleischmajer R, et al. (1988) Scleroderma: classification, subset and pathogenesis [Editorial]. J Rheumatol15, 202-5.
2. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol44, 93-151.
3. Nihtyanova SI, Denton CP (2010) Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol6, 112-6.
4. Hamaguchi Y, Hasegawa M, Fujimoto M, et al. (2008) The clinical relevance of serum antinuclear antibodies in Japanese patients with systemis sclerosis. Br J Dermatol158, 487-95.
5. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum35, 35-42.
6. Roberts-Thomson PJ, Jones M, Hakendorf P, et al. (2001) Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J31, 220-9.
7. Janssen A, Meyer W, Roberts-Thomson P, et al. (2010) Autoantibody profiling in systemic sclerosis: advantages of a multiparametric detection system. Ann Rheum Dis69 (Suppl3), 692.
8. TM ANA Update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol22, 579-88.
9. Bond C, Pile KD, McNeil JD, et al. (1998) South Australian Scleroderma Register: analysis of deceased patient. Scleroderma mortality Study. Pathology30, 386-90.
10. Hesselstrand R, Scheja G, Shen Q, Wiik A, Åkesson A (2003) The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology42, 534-40.
11. Basu D, Reveille JD (2005) Anti-scl-70. Autoimmunity38 (1), 65-72.
12. Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA Polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol37, 15-20.
13. Penn H, Howie AJ, Kingdom EJ, et al. (2007) Scleroderma renal crisis: patient characteristics and long term outcomes. Q J Med100, 485-94.
14. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA (2003) A comparison between anti-Th/To and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum48, 203-9.
15. Rozman B, Cucnik S, Sodin-Semrl S, et al. (2008) Prevalence and clinical associations of anti-ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Ann Rheum Dis67, 1282-6.
16. Mahler M, Reinout R (2007) Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev6, 432-7.
17. Hanke K, Brückner CS, Dähnrich C, et al. (2009) Antibodies against PM/SCL-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther11, R22.
18. Tormey VJ, Bunn CC, Denton CP, Black CM (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology40, 1157-62.
19. Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA (2009) Anti-U3 RNP Autoantibodies in Systemic Sclerosis. Arthritis Rheum60(4), 1112-8.